Sona Nanotech Inc
Sona Nanotech Inc. operates as a nanotechnology life sciences company. It develops targeted hyperthermia and nanomedical therapies for the treatment of cancer. The company also develops gold nanoparticle products; lateral flow assay rapid tests; and bovine TB and concussion tests. Sona Nanotech Inc. is based in Halifax, Canada.
Sona Nanotech Inc (SNANF) - Total Assets
Latest total assets as of April 2025: $2.29 Million USD
Based on the latest financial reports, Sona Nanotech Inc (SNANF) holds total assets worth $2.29 Million USD as of April 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Sona Nanotech Inc - Total Assets Trend (2016–2024)
This chart illustrates how Sona Nanotech Inc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Sona Nanotech Inc - Asset Composition Analysis
Current Asset Composition (October 2024)
Sona Nanotech Inc's total assets of $2.29 Million consist of 53.3% current assets and 46.7% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 49.5% |
| Accounts Receivable | $97.21K | 2.6% |
| Inventory | $0.00 | 0.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2016–2024)
This chart illustrates how Sona Nanotech Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Sona Nanotech Inc's current assets represent 53.3% of total assets in 2024, an increase from 3.0% in 2016.
- Cash Position: Cash and equivalents constituted 49.5% of total assets in 2024, up from 0.4% in 2016.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2016.
- Asset Diversification: The largest asset category is accounts receivable at 2.6% of total assets.
Sona Nanotech Inc Competitors by Total Assets
Key competitors of Sona Nanotech Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
ADCNF
OTCGREY:ADCNF
|
USA | $4.51 Billion |
|
Berry Genomics Co Ltd
SHE:000710
|
China | CN¥2.34 Billion |
|
Malaysian Genomics Resource
KLSE:0155
|
Malaysia | RM20.70 Million |
|
NSN Co. Ltd
KQ:031860
|
Korea | ₩60.96 Billion |
|
JOONGANG DNM Co.Ltd
KQ:051980
|
Korea | ₩121.79 Billion |
|
GeneMatrix Inc
KQ:109820
|
Korea | ₩28.03 Billion |
|
Genoray Co. Ltd
KQ:122310
|
Korea | ₩125.67 Billion |
|
Green Cross Lab Cell Corporation
KQ:144510
|
Korea | ₩565.79 Billion |
Sona Nanotech Inc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Sona Nanotech Inc generates 0.00x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Sona Nanotech Inc is currently not profitable relative to its asset base.
Sona Nanotech Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.05 | 0.10 | 0.39 |
| Quick Ratio | 1.05 | 0.10 | 0.17 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $43.37K | $ -1.05 Million | $ -2.37 Million |
Sona Nanotech Inc - Advanced Valuation Insights
This section examines the relationship between Sona Nanotech Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 135.44 |
| Latest Market Cap to Assets Ratio | 4.84 |
| Asset Growth Rate (YoY) | 36.3% |
| Total Assets | $3.75 Million |
| Market Capitalization | $18.14 Million USD |
Valuation Analysis
Premium Asset Valuation: The market values Sona Nanotech Inc's assets at a significant premium ( 4.84x), suggesting investors see substantial growth potential or unique competitive advantages.
Rapid Asset Growth: Sona Nanotech Inc's assets grew by 36.3% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Sona Nanotech Inc (2016–2024)
The table below shows the annual total assets of Sona Nanotech Inc from 2016 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-10-31 | $3.75 Million | +36.31% |
| 2023-10-31 | $2.75 Million | +427.73% |
| 2022-10-31 | $520.77K | -65.81% |
| 2021-10-31 | $1.52 Million | +110.22% |
| 2020-10-31 | $724.63K | -15.66% |
| 2019-10-31 | $859.21K | -72.96% |
| 2018-10-31 | $3.18 Million | +83.10% |
| 2017-10-31 | $1.74 Million | -64.23% |
| 2016-10-31 | $4.85 Million | -- |